My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 30

    1.

    Dickkopf 4 (DKK4) acts on Wnt/β-catenin pathway by influencing β-catenin in hepatocellular carcinoma.

    Fatima S, Lee NP, Tsang FH, Kolligs FT, Ng IO, Poon RT, Fan ST, Luk JM.

    Oncogene. 2012 Jan 16. doi: 10.1038/onc.2011.580. [Epub ahead of print]

    PMID:
    22249261
    [PubMed - as supplied by publisher]

    Related citations

    2.

    Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK1 dysregulation is an early event maintained along tumor progression.

    Petrelli A, Perra A, Schernhuber K, Cargnelutti M, Salvi A, Migliore C, Ghiso E, Benetti A, Barlati S, Ledda-Columbano GM, Portolani N, De Petro G, Columbano A, Giordano S.

    Oncogene. 2012 Jan 16. doi: 10.1038/onc.2011.631. [Epub ahead of print]

    PMID:
    22249248
    [PubMed - as supplied by publisher]

    Related citations

    3.

    MicroRNA-520e suppresses growth of hepatoma cells by targeting the NF-κB-inducing kinase (NIK).

    Zhang S, Shan C, Kong G, Du Y, Ye L, Zhang X.

    Oncogene. 2011 Nov 21. doi: 10.1038/onc.2011.523. [Epub ahead of print]

    PMID:
    22105365
    [PubMed - as supplied by publisher]

    Related citations

    4.

    TP63 P2 promoter functional analysis identifies β-catenin as a key regulator of ΔNp63 expression.

    Ruptier C, De Gaspéris A, Ansieau S, Granjon A, Tanière P, Lafosse I, Shi H, Petitjean A, Taranchon-Clermont E, Tribollet V, Voeltzel T, Scoazec JY, Maguer-Satta V, Puisieux A, Hainaut P, Cavard C, Caron de Fromentel C.

    Oncogene. 2011 Nov 17;30(46):4656-65. doi: 10.1038/onc.2011.171. Epub 2011 Jun 6.

    PMID:
    21643019
    [PubMed - indexed for MEDLINE]

    Related citations

    5.

    MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo.

    He XX, Chang Y, Meng FY, Wang MY, Xie QH, Tang F, Li PY, Song YH, Lin JS.

    Oncogene. 2011 Nov 7. doi: 10.1038/onc.2011.500. [Epub ahead of print]

    PMID:
    22056881
    [PubMed - as supplied by publisher]

    Related citations

    6.

    A novel interplay between oncogenic PFTK1 protein kinase and tumor suppressor TAGLN2 in the control of liver cancer cell motility.

    Leung WK, Ching AK, Chan AW, Poon TC, Mian H, Wong AS, To KF, Wong N.

    Oncogene. 2011 Nov 3;30(44):4464-75. doi: 10.1038/onc.2011.161. Epub 2011 May 16.

    PMID:
    21577206
    [PubMed - indexed for MEDLINE]

    Related citations

    7.

    HAb18G/CD147 promotes epithelial-mesenchymal transition through TGF-β signaling and is transcriptionally regulated by Slug.

    Wu J, Ru NY, Zhang Y, Li Y, Wei D, Ren Z, Huang XF, Chen ZN, Bian H.

    Oncogene. 2011 Oct 27;30(43):4410-27. doi: 10.1038/onc.2011.149. Epub 2011 May 2.

    PMID:
    21532623
    [PubMed - indexed for MEDLINE]

    Related citations

    8.

    Somatic LMCD1 mutations promoted cell migration and tumor metastasis in hepatocellular carcinoma.

    Chang CY, Lin SC, Su WH, Ho CM, Jou YS.

    Oncogene. 2012 May 24;31(21):2640-52. doi: 10.1038/onc.2011.440. Epub 2011 Sep 26.

    PMID:
    21996735
    [PubMed - in process]

    Related citations

    9.

    Development of a Listeria monocytogenes-based vaccine against hepatocellular carcinoma.

    Chen Y, Yang D, Li S, Gao Y, Jiang R, Deng L, Frankel FR, Sun B.

    Oncogene. 2012 Apr 26;31(17):2140-52. doi: 10.1038/onc.2011.395. Epub 2011 Sep 19.

    PMID:
    21927025
    [PubMed - in process]

    Related citations

    10.

    MTSS1, a novel target of DNA methyltransferase 3B, functions as a tumor suppressor in hepatocellular carcinoma.

    Fan H, Chen L, Zhang F, Quan Y, Su X, Qiu X, Zhao Z, Kong KL, Dong S, Song Y, Chan TH, Guan XY.

    Oncogene. 2012 May 3;31(18):2298-308. doi: 10.1038/onc.2011.411. Epub 2011 Sep 12.

    PMID:
    21909138
    [PubMed - in process]

    Related citations

    11.

    Type IV collagen-initiated signals provide survival and growth cues required for liver metastasis.

    Burnier JV, Wang N, Michel RP, Hassanain M, Li S, Lu Y, Metrakos P, Antecka E, Burnier MN, Ponton A, Gallinger S, Brodt P.

    Oncogene. 2011 Sep 1;30(35):3766-83. doi: 10.1038/onc.2011.89. Epub 2011 Apr 11.

    PMID:
    21478904
    [PubMed - indexed for MEDLINE]

    Related citations

    12.

    Methylation of an intronic region regulates miR-199a in testicular tumor malignancy.

    Cheung HH, Davis AJ, Lee TL, Pang AL, Nagrani S, Rennert OM, Chan WY.

    Oncogene. 2011 Aug 4;30(31):3404-15. doi: 10.1038/onc.2011.60. Epub 2011 Mar 7.

    PMID:
    21383689
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    13.

    Microsomal prostaglandin E synthase-1 promotes hepatocarcinogenesis through activation of a novel EGR1/β-catenin signaling axis.

    Lu D, Han C, Wu T.

    Oncogene. 2012 Feb 16;31(7):842-57. doi: 10.1038/onc.2011.287. Epub 2011 Jul 11.

    PMID:
    21743491
    [PubMed - indexed for MEDLINE]

    Related citations

    14.

    Retraction. Androgen activates PEG10 to promote carcinogenesis in hepatic cancer cells.

    [No authors listed]

    Oncogene. 2011 Jun 16;30(24):2798. doi: 10.1038/onc.2011.66. No abstract available.

    PMID:
    21677654
    [PubMed - indexed for MEDLINE]

    Related citations

    15.

    microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer.

    Braconi C, Kogure T, Valeri N, Huang N, Nuovo G, Costinean S, Negrini M, Miotto E, Croce CM, Patel T.

    Oncogene. 2011 Nov 24;30(47):4750-6. doi: 10.1038/onc.2011.193. Epub 2011 May 30.

    PMID:
    21625215
    [PubMed - indexed for MEDLINE]

    Related citations

    16.

    In melanoma, beta-catenin is a suppressor of invasion.

    Arozarena I, Bischof H, Gilby D, Belloni B, Dummer R, Wellbrock C.

    Oncogene. 2011 Nov 10;30(45):4531-43. doi: 10.1038/onc.2011.162. Epub 2011 May 16.

    PMID:
    21577209
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    17.

    Molecular targeting of CSN5 in human hepatocellular carcinoma: a mechanism of therapeutic response.

    Lee YH, Judge AD, Seo D, Kitade M, Gómez-Quiroz LE, Ishikawa T, Andersen JB, Kim BK, Marquardt JU, Raggi C, Avital I, Conner EA, MacLachlan I, Factor VM, Thorgeirsson SS.

    Oncogene. 2011 Oct 6;30(40):4175-84. doi: 10.1038/onc.2011.126. Epub 2011 Apr 18.

    PMID:
    21499307
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    18.

    Efficient in vivo microRNA targeting of liver metastasis.

    Huynh C, Segura MF, Gaziel-Sovran A, Menendez S, Darvishian F, Chiriboga L, Levin B, Meruelo D, Osman I, Zavadil J, Marcusson EG, Hernando E.

    Oncogene. 2011 Mar 24;30(12):1481-8. Epub 2010 Nov 22.

    PMID:
    21102518
    [PubMed - indexed for MEDLINE]

    Related citations

    19.

    hSSB1 binds and protects p21 from ubiquitin-mediated degradation and positively correlates with p21 in human hepatocellular carcinomas.

    Xu S, Feng Z, Zhang M, Wu Y, Sang Y, Xu H, Lv X, Hu K, Cao J, Zhang R, Chen L, Liu M, Yun JP, Zeng YX, Kang T.

    Oncogene. 2011 May 12;30(19):2219-29. Epub 2011 Jan 17.

    PMID:
    21242961
    [PubMed - indexed for MEDLINE]

    Related citations

    20.

    Cathepsin H regulated by the thyroid hormone receptors associate with tumor invasion in human hepatoma cells.

    Wu SM, Huang YH, Yeh CT, Tsai MM, Liao CH, Cheng WL, Chen WJ, Lin KH.

    Oncogene. 2011 Apr 28;30(17):2057-69. Epub 2011 Jan 10.

    PMID:
    21217776
    [PubMed - indexed for MEDLINE]

    Related citations

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Filters: Manage Filters

      Find related data

      Recent activity

      Clear Turn Off Turn On

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      You are here: NCBI > Literature > PubMed
      Write to the Help Desk